Molecular Partners Publishes Audited Financial Results for 2018 and Annual Report 2018
(WorldNews Switzerland)

Zurich-Schlieren, March 15, 2019. Molecular Partners AG (SIX: MOLN), a clinical-stage biotech company pioneering the use of DARPin® therapeutics* to treat serious diseases, today published its audited Financial Results for 2018 and the company`s 2018 Annual Report. The Audited Financial Results for 2018 and the company`s 2018 Annual Report are available on the investors section of the company` website. Financial Calendar March 19, 2019 - Expected Publication of Invitation to Annual General Meeting April 16, 2019 - Annual General Meeting May 9, 2019 - Interim Management Statement Q1 2019 August 27, 2019 - Publication of Half-year Results 2019 (unaudited) October 31, 2019 - Interim Management...